fasudil has been researched along with Schizophrenia in 3 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Excerpt | Relevance | Reference |
---|---|---|
"Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance." | 5.72 | Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia. ( Kaibuchi, K; Liao, J; Liu, Y; Miyagawa, Y; Mizoguchi, H; Nagai, T; Ozaki, N; Sawahata, M; Sobue, A; Takase, S; Tanaka, R; Yamada, K, 2022) |
"Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance." | 1.72 | Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia. ( Kaibuchi, K; Liao, J; Liu, Y; Miyagawa, Y; Mizoguchi, H; Nagai, T; Ozaki, N; Sawahata, M; Sobue, A; Takase, S; Tanaka, R; Yamada, K, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Takase, S | 1 |
Liao, J | 5 |
Liu, Y | 2 |
Tanaka, R | 4 |
Miyagawa, Y | 1 |
Sawahata, M | 2 |
Sobue, A | 1 |
Mizoguchi, H | 5 |
Nagai, T | 5 |
Kaibuchi, K | 5 |
Ozaki, N | 5 |
Yamada, K | 5 |
Hada, K | 3 |
Mori, D | 3 |
Matsuzaki, T | 3 |
Nabeshima, T | 4 |
Dong, G | 1 |
Zhu, W | 1 |
Wulaer, B | 1 |
3 other studies available for fasudil and Schizophrenia